For global distributors and aesthetic clinics, the primary procurement driver is batch-to-batch consistency. Our manufacturing facility utilizes automated titration and precision laser calibration to ensure every device and serum meets international pharmacopeia standards.
Navigating FDA, CE, and NMPA certifications is non-negotiable for enterprise buyers. We provide comprehensive technical dossiers and clinical efficacy reports, reducing the time-to-market for our partners in North America, EU, and Asia-Pacific regions.
Beyond stock inventory, enterprises seek "Information Gain" via exclusive formulations. We offer custom PDRN concentrations and proprietary laser wavelengths (1550nm/1927nm) tailored to specific demographic skin types, from Glogau I to IV.
The global "pore-less" skin trend has shifted from temporary cosmetic camouflage to long-term dermatological restructuring. As a leading manufacturer, we address this through a dual-track technological approach.
Utilizing PDRN (Polydeoxyribonucleotide) and Salmon DNA, our solutions target the dermal matrix. By stimulating fibroblasts, we increase skin elasticity, which naturally constricts enlarged pores caused by structural sagging (aging-related pore dilation).
Our Thulium Laser (1927nm) technology provides sub-ablative resurfacing. This "Baby Face" laser creates micro-thermal zones that trigger a rapid healing response, replacing damaged follicular walls with tight, new tissue.
Clinical Efficacy Rate
Exporting Countries
Global Partner Clinics
Phase 1: Mechanical Extraction (Legacy) - Traditional vacuum and physical exfoliation. While effective for immediate debris removal (Blackhead Removers), it lacks long-term structural benefits.
Phase 2: Chemical & Enzyme Modulation (Current) - AHA/BHA/LHA ampoules. These provide chemical keratolysis to keep the pore "tunnel" clear, preventing the stretching caused by sebum plugs.
Phase 3: Energy-Based Tissue Remodeling (Advanced) - The integration of Thulium lasers and Hydradermabrasion with intelligent water circulation. This phase focuses on the "Basement Membrane Zone" (BMZ) to shrink the physical diameter of the pore.
Phase 4: AI-Driven Personalized Diagnostics (Future) - We are currently researching integrated cameras in suction devices that analyze sebum oxidation levels in real-time, adjusting suction power and thermal cooling dynamically.
Founded in 2009, Jiangsu Menuka Medical Co., Ltd. is a leading innovator in the field of medical skincare and dermatological solutions. As a modern enterprise integrating R&D, intelligent manufacturing, clinical application, and global distribution, Menuka Medical is dedicated to advancing the future of professional skincare through science, safety, and innovation.
With years of expertise in dermatology and post-procedure skincare, Menuka Medical continuously develops advanced formulations and functional skincare products supported by patented technologies, clinical validation, and strict quality standards.
At Menuka Medical, we believe skincare is more than a daily routine — it is a professional solution. Every formula undergoes rigorous research, testing, and quality control. We focus on: Clinical efficacy, Safety, Post-procedure recovery, and Long-term skin health.
Meeting FDA Class II medical device requirements for vacuum suction and light-based therapy devices. We support UL/ETL safety testing for all electronic hardware.
CE MDD/MDR compliance for aesthetic lasers. Our PDRN serums comply with CPNP registration and REACH standards for cosmetic ingredients.
Localization of product manuals and training programs. We offer HALAL-friendly ingredient sourcing for topical serums and ampoules.
PDRN (Polydeoxyribonucleotide) derived from salmon DNA is a powerful regenerative ingredient. Unlike astringents that temporarily tighten skin, PDRN works at the cellular level to repair the dermal layer, increasing collagen density and reducing the "stretched" appearance of pores permanently.
While CO2 lasers are ablative and require significant downtime, our 1927nm Thulium laser is sub-ablative. It targets the upper dermis where pores reside without removing the entire epidermal layer, resulting in faster healing and lower risk of post-inflammatory hyperpigmentation (PIH).
Yes, Jiangsu Menuka Medical offers full-spectrum OEM/ODM services. This includes custom branding for blackhead remover devices and proprietary formulations for AHA/BHA/LHA pore-tightening ampoules.
Typically, standard stock items are shipped within 7-10 business days. Custom OEM projects involving new formulations or housing designs generally range from 30 to 45 days, depending on regulatory testing requirements.
Menuka Medical
